Breast Cancer Risk for Women With a TP53 Pathogenic Variant Reply

被引：0
|
作者：
Fortuno, Cristina [1 ]
Spurdle, Amanda B. [1 ]
James, Paul A. [2 ,3 ]
机构：
[1] QIMR Berghofer Med Res Inst, Populat Hlth Program, Brisbane, Qld, Australia
[2] Peter MacCallum Canc Ctr, Parkville Familial Canc Ctr, Melbourne, Vic, Australia
[3] Royal Melbourne Hosp, Melbourne, Vic, Australia
来源：
JCO PRECISION ONCOLOGY | 2024年 / 8卷
关键词：
D O I：
10.1200/PO.24.00270
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Breast Cancer Risk for Women With a TP53 Pathogenic Variant
    Li, Shuai
    Hopper, John L.
    JCO PRECISION ONCOLOGY, 2024, 8
  • [2] TP53 and breast cancer
    Borresen-Dale, AL
    HUMAN MUTATION, 2003, 21 (03) : 292 - 300
  • [3] Phenotype and prognosis of patients with breast cancer and pathogenic TP53 variants
    Petry, Vanessa
    CANCER RESEARCH, 2021, 81 (04)
  • [4] Germline TP53 pathogenic variants and breast cancer: A narrative review
    Blondeaux, Eva
    Arecco, Luca
    Punie, Kevin
    Graffeo, Rossella
    Toss, Angela
    De Angelis, Carmine
    Trevisan, Lucia
    Buzzatti, Giulia
    Linn, Sabine C.
    Dubsky, Peter
    Cruellas, Mara
    Partridge, Ann H.
    Balman, Judith
    Paluch-Shimon, Shani
    Lambertini, Matteo
    CANCER TREATMENT REVIEWS, 2023, 114
  • [5] An intronic variant in the TP53 gene in a Brazilian woman with breast cancer
    Lacerda, LL
    Serrano, SV
    Mathes, A
    Rey, JA
    Bello, MJ
    Casartelli, C
    CANCER GENETICS AND CYTOGENETICS, 2005, 160 (02) : 160 - 163
  • [6] TP53 mutations as a prognostic factor in women with breast cancer
    Marie Lofthouse
    Nature Clinical Practice Oncology, 2005, 2 (9): : 428 - 429
  • [7] Breast cancer risk:tp53 genotyping in a Nigerian population
    Kasvosve, Nancy N.
    Fackenthal, Jim
    Zhang, Jing
    Olopade, Olufunmilayo
    CANCER RESEARCH, 2010, 70
  • [8] An intronic variant in the TP53 gene in Serbian women with cervical or ovarian cancer
    Malisic, Emma J.
    Jankovic, Radmila N.
    Radulovic, Sinisa S.
    CANCER GENETICS AND CYTOGENETICS, 2010, 198 (02) : 173 - 175
  • [9] Case series of Li-Fraumeni syndrome: carcinogenic mechanisms in breast cancer with TP53 pathogenic variant carriers
    Hosonaga, Mari
    Habano, Eri
    Arakawa, Hiromi
    Kaneko, Keika
    Nakajima, Takeshi
    Hayashi, Naomi
    Fukada, Ippei
    Nakamura, Akira
    Haruyama, Yurie
    Maeda, Tetsuyo
    Inari, Hitoshi
    Kobayashi, Takayuki
    Nakashima, Eri
    Ueno, Takayuki
    Takano, Toshimi
    Takahashi, Shunji
    Ohno, Shinji
    Ueki, Arisa
    BREAST CANCER, 2024, 31 (05) : 988 - 996
  • [10] A functionally significant SNP in TP53 and breast cancer risk in African-American women
    Murphy, Maureen E.
    Liu, Song
    Yao, Song
    Huo, Dezheng
    Liu, Qin
    Dolfi, Sonia C.
    Hirshfield, Kim M.
    Hong, Chi-Chen
    Hu, Qiang
    Olshan, Andrew F.
    Ogundiran, Temidayo O.
    Adebamowo, Clement
    Domchek, Susan M.
    Nathanson, Katherine L.
    Nemesure, Barbara
    Ambs, Stefan
    Blot, William J.
    Feng, Ye
    John, Esther M.
    Bernstein, Leslie
    Zheng, Wei
    Hu, Jennifer J.
    Ziegler, Regina G.
    Nyante, Sarah
    Ingles, Sue A.
    Press, Michael F.
    Deming, Sandra L.
    Rodriguez-Gil, Jorge L.
    Haiman, Christopher A.
    Olopade, Olufunmilayo I.
    Lunetta, Kathryn L.
    Palmer, Julie R.
    Ambrosone, Christine B.
    NPJ BREAST CANCER, 2017, 3
12345